Plus Therapeutics is a U.S. clinical- stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with difficult-to-treat cancer. Their mission? To solve the toughest challenges in oncology by improving the efficacy, precision, and convenience of radiotherapeutics.New to Plus Therapeutics is the ReSPECT-GBM Clinical Trial featuring a helpful guide for patients with glioblastoma. This booklet is a study guide for patients that breaks down the ReSPECT-GBM clinical trial in simple yet educational terms and answers patients’ frequently asked questions. It explains what the clinical trial is, how it works, patient eligibility, risks/benefits, and what happens on each …